| Primary | Positive Percent Agreement of Blinded Visual Assessment of Each Participant's DaTscan Image - Intent-to-diagnose (ITD) Population | The majority blinded visual interpretation of each participant's image (3 blinded readers) was compared to his/her final clinical diagnosis, and the image interpretation was classified as true positive, false positive, true negative, or false negative. The counts of each classification type were used to determine the positive percent agreement (PPA, analogous to sensitivity) of the blinded visual image interpretations. The majority assessment was based on ≥ 2 of the 3 readers in agreement on the assessment. | ITD population that included all participants who underwent SPECT imaging after receiving DaTscan™ and enrolled in the study. Here, number of participants analyzed = participants with available data for this outcome measure. | Posted | | Number | 95% Confidence Interval | Positive percent agreement | | Day 1 | | | | ID | Title | Description |
|---|
| OG000 | DaTscan™ - Non-Caucasian Participants | Non-Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging and had a final clinical diagnosis of PD. | | OG001 | DaTscan™ - Caucasian Participants | Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging and had a final clinical diagnosis of PD. |
| | | Title | Denominators | Categories |
|---|
| Reader A | - ParticipantsOG00057
- ParticipantsOG00157
| |
| | Group IDs | Group Description | Statistical Method | Statistical Comment | P-Value | P-Value Comment | Parameter Type | Parameter Value | Dispersion Type | Dispersion Value | Confidence Interval Sides | Confidence Interval % | CI Lower Limit | CI Upper Limit | CI Lower Limit Comment | CI Upper Limit Comment | Estimate Comment | Tested Non-Inferiority | Non-Inferiority Type | Non-Inferiority Comment | Other Analysis Description |
|---|
| Reader A: DaTscan™- Non-Caucasian Participants vs DaTscan™- Caucasian Participants | Fisher Exact | | 1.0000 | | Mean Difference (Net) | 1.8 | | | 2-Sided | 95 | -17.3 | 20.7 | | | | | Equivalence | Analysis was performed using the hypothesis: PPA was equal for Caucasian and non-Caucasian populations. | | |
|
| Primary | Positive Percent Agreement of Blinded Visual Assessment of Each Participant's DaTscan Image - Per Protocol (PP) Population | The majority blinded visual interpretation of each participant's image (3 blinded readers) was compared to his/her final clinical diagnosis, and the image interpretation was classified as true positive, false positive, true negative, or false negative. The counts of each classification type were used to determine the positive percent agreement (PPA, analogous to sensitivity) of the blinded visual image interpretations. The majority assessment was based on ≥ 2 of the 3 readers in agreement on the assessment. | PP population consisted of all participants who met inclusion/exclusion criteria, had DaTscan™ image sets that were considered evaluable by ≥2 of the 3 blinded readers, and had no major protocol violations from any of the matched pair participants. Here, number of participants analyzed = participants with available data for this outcome measure. | Posted | | Number | 95% Confidence Interval | Positive percent agreement | | Day 1 | | | | ID | Title | Description |
|---|
| OG000 | DaTscan™ - Non-Caucasian Participants | Non-Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging, were included in PP population and had a final clinical diagnosis of PD. | | OG001 | DaTscan™ - Caucasian Participants | Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging, were included in PP population and had a final clinical diagnosis of PD. |
|
| Primary | Negative Percent Agreement of Blinded Visual Assessment of Each Participant's DaTscan Image - Intent-to-diagnose (ITD) Population | The majority blinded visual interpretation of each participant's image (3 blinded readers) was compared to his/her final clinical diagnosis, and the image interpretation was classified as true positive, false positive, true negative, or false negative. The counts of each classification type were used to determine the negative percent agreement (NPA, analogous to specificity) of the blinded visual image interpretations. The majority assessment was based on ≥ 2 of the 3 readers in agreement on the assessment. | ITD population that included all participants who underwent SPECT imaging after receiving DaTscan™ and enrolled in the study. Here, number of participants analyzed = participants with available data for this outcome measure. | Posted | | Number | 95% Confidence Interval | Negative percent agreement | | Day 1 | | | | ID | Title | Description |
|---|
| OG000 | DaTscan™- Non-Caucasian Participants | Non-Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging and had a final clinical diagnosis of ET. | | OG001 | DaTscan™- Caucasian Participants | Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging and had a final clinical diagnosis of ET. |
|
| Primary | Negative Percent Agreement of Blinded Visual Assessment of Each Participant's DaTscan Image - Per Protocol (PP) Population | The majority blinded visual interpretation of each participant's image (3 blinded readers) was compared to his/her final clinical diagnosis, and the image interpretation was classified as true positive, false positive, true negative, or false negative. The counts of each classification type were used to determine the negative percent agreement (NPA, analogous to specificity) of the blinded visual image interpretations. The majority assessment was based on ≥ 2 of the 3 readers in agreement on the assessment. | PP population consisted of all participants who met inclusion/exclusion criteria, had DaTscan™ image sets that were considered evaluable by ≥2 of the 3 blinded readers, and had no major protocol violations from any of the matched pair participants. Here, number of participants analyzed = participants with available data for this outcome measure. | Posted | | Number | 95% Confidence Interval | Negative percent agreement | | Day 1 | | | | ID | Title | Description |
|---|
| OG000 | DaTscan™ - Non-Caucasian Participants | Non-Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging, were included in PP population and had a final clinical diagnosis of ET. | | OG001 | DaTscan™ - Caucasian Participants | Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging, were included in PP population and had a final clinical diagnosis of ET. |
|
| Secondary | Overall Percent Agreement of Blinded Visual Assessment of Each Participant's DaTscan Image - Intent-to-diagnose (ITD) Population | Overall percent agreement (OPA) regardless of image interpretation (analogous to accuracy; ratio of number of true results / number of all participants) for each racial group, was tested to determine if it was greater than 80% in both racial groups. The majority assessment was based on ≥2 of the 3 readers in agreement on the assessment. | The intent-to-diagnose (ITD) population that included all participants who underwent SPECT imaging after receiving DaTscan™ and enrolled in the study. Here, number of participants analyzed = participants with available data for this outcome measure. | Posted | | Number | 95% Confidence Interval | Overall percent agreement | | Day 1 | | | | ID | Title | Description |
|---|
| OG000 | DaTscan™- Non-Caucasian Participants | Non-Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging to assist with the participant's final clinical diagnosis of PD or ET. | | OG001 | DaTscan™- Caucasian Participants | Caucasian participants previously administered DaTscan™, with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging to assist with the participant's final clinical diagnosis of PD or ET. |
| |
| Secondary | Overall Percent Agreement of Blinded Visual Assessment of Each Participant's DaTscan Image - Per Protocol (PP) Population | Overall percent agreement (OPA) regardless of image interpretation (analogous to accuracy; ratio of number of true results / number of all participants) for each racial group, was tested to determine if it was greater than 80% in both racial groups. The majority assessment was based on ≥2 of the 3 readers in agreement on the assessment. | PP population consisted of all participants who met inclusion/exclusion criteria, had DaTscan™ image sets that were considered evaluable by ≥2 of the 3 blinded readers, and had no major protocol violations from any of the matched pair participants. Here, number of participants analyzed = participants with available data for this outcome measure. | Posted | | Number | 95% Confidence Interval | Overall percent agreement | | Day 1 | | | | ID | Title | Description |
|---|
| OG000 | DaTscan™- Non-Caucasian Participants | Non-Caucasian participants previously administered DaTscan™, included in PP population with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging to assist with the participant's final clinical diagnosis of PD or ET. | | OG001 | DaTscan™- Caucasian Participants | Caucasian participants previously administered DaTscan™, included in PP population with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging to assist with the participant's final clinical diagnosis of PD or ET. |
|